G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 102 filers reported holding G1 THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $50,606 | -86.2% | 35,143 | -76.2% | 0.00% | – |
Q2 2023 | $367,025 | -47.9% | 147,400 | -44.0% | 0.00% | – |
Q1 2023 | $705,008 | -65.0% | 263,063 | -29.0% | 0.00% | – |
Q4 2022 | $2,012,755 | -52.4% | 370,673 | +9.6% | 0.00% | -100.0% |
Q3 2022 | $4,225,000 | +367.9% | 338,294 | +85.2% | 0.00% | – |
Q2 2022 | $903,000 | -56.8% | 182,651 | -33.6% | 0.00% | – |
Q1 2022 | $2,090,000 | -43.4% | 274,958 | -24.0% | 0.00% | – |
Q4 2021 | $3,694,000 | -20.5% | 361,818 | +4.4% | 0.00% | -100.0% |
Q3 2021 | $4,649,000 | -63.0% | 346,414 | -39.4% | 0.00% | -50.0% |
Q2 2021 | $12,551,000 | +120.6% | 572,061 | +142.0% | 0.00% | +100.0% |
Q1 2021 | $5,689,000 | +35.0% | 236,426 | +0.9% | 0.00% | 0.0% |
Q4 2020 | $4,213,000 | +159.9% | 234,220 | +66.9% | 0.00% | – |
Q3 2020 | $1,621,000 | +55.6% | 140,352 | +226.4% | 0.00% | – |
Q2 2020 | $1,042,000 | -37.9% | 42,998 | -71.8% | 0.00% | – |
Q1 2020 | $1,678,000 | -9.1% | 152,381 | +118.2% | 0.00% | – |
Q4 2019 | $1,845,000 | -49.7% | 69,834 | -56.6% | 0.00% | -100.0% |
Q3 2019 | $3,666,000 | +752.6% | 160,940 | +1047.6% | 0.00% | – |
Q2 2019 | $430,000 | -92.7% | 14,024 | -96.1% | 0.00% | -100.0% |
Q1 2019 | $5,906,000 | +49.5% | 355,742 | +72.5% | 0.00% | +100.0% |
Q4 2018 | $3,950,000 | +105.5% | 206,244 | +461.1% | 0.00% | – |
Q3 2018 | $1,922,000 | +0.8% | 36,756 | -16.2% | 0.00% | -100.0% |
Q2 2018 | $1,907,000 | +68.0% | 43,872 | +43.2% | 0.00% | – |
Q1 2018 | $1,135,000 | +255.8% | 30,640 | +90.4% | 0.00% | – |
Q4 2017 | $319,000 | +27.6% | 16,089 | +59.9% | 0.00% | – |
Q3 2017 | $250,000 | +681.2% | 10,062 | +453.5% | 0.00% | – |
Q2 2017 | $32,000 | – | 1,818 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |